{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:10:58Z","timestamp":1790734258476,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ajo.2008.01.019","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T09:12:30Z","timestamp":1206781950000},"page":"959-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Clinical Cure of Bacterial Conjunctivitis with Azithromycin 1%: Vehicle-Controlled, Double-Masked Clinical Trial"],"prefix":"10.1016","volume":"145","author":[{"given":"Mark B.","family":"Abelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle M.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2008.01.019_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(81)80754-8","article-title":"Etiology of acute conjunctivitis in children","volume":"98","author":"Gigliotti","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajo.2008.01.019_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bjo.66.6.357","article-title":"Aetiology and treatment of acute bacterial infection of the external eye","volume":"66","author":"Seal","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/bjo.87.8.1004","article-title":"A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis","volume":"87","author":"Hwang","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib4","first-page":"64","article-title":"Pneumococcal conjunctivitis at an elementary school\u2014Maine, September 20\u2013December 6, 2002","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajo.2008.01.019_bib5","series-title":"Conjunctivitis, Preferred Practice Pattern","year":"2003"},{"key":"10.1016\/j.ajo.2008.01.019_bib6","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2174\/1381612043383322","article-title":"The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview","volume":"10","author":"Jain","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajo.2008.01.019_bib7","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.06-1413","article-title":"Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis","volume":"48","author":"Protzko","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2008.01.019_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijantimicag.2005.04.017","article-title":"A systematic review and meta-analysis of misuse of antibiotic therapies in the community","volume":"26","author":"Kardas","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajo.2008.01.019_bib9","first-page":"775","article-title":"Part I","volume":"14","author":"Kass","year":"1982","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/02713688109069178","article-title":"Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study","volume":"1","author":"Cagle","year":"1981","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2008.01.019_bib11","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":"An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data","volume":"112","author":"Kowalski","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.01.019_bib12","first-page":"177","article-title":"A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis","volume":"1","author":"Abelson","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":"The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in NZW rabbit model","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib14","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1185\/030079904X5959","article-title":"A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability","volume":"20","author":"Donnenfeld","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajo.2008.01.019_bib15","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1167\/iovs.06-0224","article-title":"Fluoroquinolone eye drop induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis","volume":"47","author":"Dutot","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2008.01.019_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/archopht.1992.01080160106043","article-title":"Preservative-free artificial tear preparations","volume":"110","author":"Berdy","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.01.019_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0924-8579(01)00430-7","article-title":"Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes","volume":"18","author":"Hand","year":"2001","journal-title":"Int J Antimicrob Agents"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:56:28Z","timestamp":1757595388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939408000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0002939408000810"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2008.01.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Cure of Bacterial Conjunctivitis with Azithromycin 1%: Vehicle-Controlled, Double-Masked Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2008.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}